Literature DB >> 3646181

Emergence of coagulase negative staphylococci as major nosocomial bloodstream pathogens.

R I Stillman, R P Wenzel, L C Donowitz.   

Abstract

Over an eight year period, 1975 to 1982, 1,843 nosocomial bloodstream infections were identified by routine prospective surveillance at the University of Virginia Hospital (106/10,000 admissions). Despite a decline in overall bloodstream infection rates during the study period (P = .085), bloodstream infections due to gram positive organisms increased from 29 (1975-1978) to 43/10,000 (1979-1982), (P less than 0.001). Notably, rates for coagulase negative staphylococci increased from 5.2 (1975-1978) to 12.4/10,000 (1979-1982), (P less than 0.001). In 1982, coagulase negative staphylococci accounted for 17% of all bloodstream infections and were the most frequently isolated pathogens. Sixty-four percent of patients with coagulase negative staphylococci were in critical care units versus 41% with other bloodstream infections (P less than .05). The recognition of coagulase negative staphylococci as significant bloodstream pathogens markedly alters the clinician's approach to nosocomial septicemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3646181     DOI: 10.1017/s0195941700067278

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  15 in total

Review 1.  Recurrent Staphylococcus warnerii prosthetic valve endocarditis: a case report and review.

Authors:  Ferhat Arslan; Nese Saltoglu; Birgül Mete; Ali Mert
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-04-23       Impact factor: 3.944

2.  Polymicrobial septicaemia and Clostridium difficile.

Authors:  P N Levett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

3.  Detection of bacteremia by Difco ESP blood culture system.

Authors:  J A Morello; C Leitch; S Nitz; J W Dyke; M Andruszewski; G Maier; W Landau; M A Beard
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

Review 4.  An overview of nosocomial infections, including the role of the microbiology laboratory.

Authors:  T G Emori; R P Gaynes
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria.

Authors:  A King; L Bethune; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 6.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department.

Authors:  J L Nouwen; A van Belkum; S de Marie; J Sluijs; J J Wielenga; J A Kluytmans; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.

Authors:  C P Timmerman; E Mattsson; L Martinez-Martinez; L De Graaf; J A Van Strijp; H A Verbrugh; J Verhoef; A Fleer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Clinical significance of Staphylococcus warneri bacteremia.

Authors:  U Kamath; C Singer; H D Isenberg
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Capsular polysaccharide serotyping scheme for Staphylococcus epidermidis.

Authors:  A Fattom; S Shepherd; W Karakawa
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.